Displaying drugs 8476 - 8500 of 9230 in total
Nelotanserin
Nelotanserin has been used in trials studying the treatment of Lewy Body Dementia, Visual Hallucinations, Dementia With Lewy Bodies, and REM Sleep Behavior Disorder. It is a highly selective antagonist at the 5-HT2A serotonin receptor. It increases non-REM sleep, the most restorative phase of the sleep cycle, without sacrificing REM...
Investigational
Tonapofylline
Tonapofylline has been used in trials studying the treatment of Heart Failure, Renal Insufficiency, and Congestive Heart Failure.
Investigational
Mavoglurant
Mavoglurant has been used in trials studying the treatment of Patient Diagnosed With OCD and and Resistant to SSRI Treatment (Failed SSRI Over 12 Weeks at Appropriate Doses).
Investigational
Visnadine
Experimental
Investigational
Phenibut
Experimental
Guacetisal
Experimental
Tetramethrin
Experimental
Fedrilate
Experimental
Tenivastatin
Experimental
O2-Sulfo-Glucuronic Acid
Experimental
L-[(N-Hydroxyamino)Carbonyl]Phenylalanine
Experimental
5-Amino-3-Methyl-Pyrrolidine-2-Carboxylic Acid
Experimental
N-Dimethyl-Lysine
Experimental
L-serine O-sulfate
Experimental
1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
Experimental
D-[(N-Hydroxyamino)Carbonyl]Phenylalanine
Experimental
Mesobiliverdin IV alpha
Experimental
Merimepodib
Merimepodib (VX-497) is a novel noncompetitive inhibitor of IMPDH. Merimepodib is orally bioavailable and inhibits the proliferation of primary human, mouse, rat, and dog lymphocytes at concentrations of approximately 100 nM.
Investigational
Ecabet
Ecabet is a prescription eye drop for the treatment of dry eye syndrome. Ecabet represents a new class of molecules that increases the quantity and quality of mucin produced by conjunctival goblet cells and corneal epithelia. Mucin is a glycoprotein component of tear film that lubricates while retarding moisture loss...
Investigational
Displaying drugs 8476 - 8500 of 9230 in total